Evidence Gaps

Indacaterol vs placebo

Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive… 2015 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 5001 participants
High

Indacaterol vs long‐acting beta2‐agonist alone

Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive… 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 2708 participants
High